Diabetes technology & therapeutics

Keyphrases

Publications

volume 26, number 9, 2024

Alanna Weisman, Gillian L Booth, Karl Everett, George A Tomlinson
Recent Improvements in Attainment of the Hemoglobin A1c Target of ≤7.0% Among Adults with Type 1 Diabetes in Ontario: A Retrospective Cohort Study. Diabetes technology & therapeutics 26 (9) (2024)
Schafer C Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard, Phillip Banks, Jeremy Pettus, Satish Garg
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes technology & therapeutics 26 (9) (2024)
Alex Mesa, Clara Solà, Irene Vinagre, Daria Roca, Montse Granados, Irene Pueyo, Carla Cabré, Ignacio Conget, Marga Giménez
Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women with Type 1 Diabetes Prone to Hypoglycemia. Diabetes technology & therapeutics 26 (9) (2024)
Lauren A Waterman, Laura Pyle, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa, Erin C Cobry
Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes technology & therapeutics 26 (9) (2024)
Irl B Hirsch, Amir Tirosh, Ami Navon
Noninvasive Real-Time Glucose Monitoring Is in the Near Future. Diabetes technology & therapeutics 26 (9) (2024)
Anirban Roy, Benyamin Grosman, Andrea Benedetti, Bahman Engheta, Diana Miller, Maya Laron-Hirsh, Yael Cohen, Roseline Ré, Shannon N Edd, Robert A Vigersky, Ohad Cohen, Amir Tirosh
An Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing Algorithm. Diabetes technology & therapeutics 26 (9) (2024)

volume 26, number S1, 2024

Thomas W Martens, Gregg D Simonson, Anders L Carlson, Richard M Bergenstal
Primary Care and Diabetes Technologies and Treatments. Diabetes technology & therapeutics 26 (S1) (2024)
Mark A Clements, Neal Kaufman, Eran Mel
Using Digital Health Technology to Prevent and Treat Diabetes. Diabetes technology & therapeutics 26 (S1) (2024)
Moshe Phillip, Tadej Battelino
Technologies in Diabetes-the Fifteenth ATTD Yearbook. Diabetes technology & therapeutics 26 (S1) (2024)
Satish K Garg, Gurleen Kaur, Amanda H Rewers, Irl B Hirsch
New Medications for the Treatment of Diabetes. Diabetes technology & therapeutics 26 (S1) (2024)
Francesco Prattichizzo, Antonio Ceriello, Viral N Shah
Obesity, NAFLD/NASH, and Diabetes. Diabetes technology & therapeutics 26 (S1) (2024)
Thomas Danne, Lutz Heinemann, Thomas R Pieber
New Insulins, Biosimilars, and Insulin Therapy. Diabetes technology & therapeutics 26 (S1) (2024)
Michael C Riddell, Dorsa Shakeri, Carmel E Smart, Dessi P Zaharieva
Advances in Exercise and Nutrition as Therapy in Diabetes . Diabetes technology & therapeutics 26 (S1) (2024)
Ananta Addala, Stuart A Weinzimer
Diabetes Technology in the "Real World": Expanding Access and Addressing Disparities. Diabetes technology & therapeutics 26 (S1) (2024)
Satish K Garg, Amanda H Rewers, Gurleen Kaur
Virtual Clinics for Diabetes Care. Diabetes technology & therapeutics 26 (S1) (2024)
Bimota Nambam, Nataša Bratina, Desmond A Schatz
Immune Intervention and Replacement Therapies in Type 1 Diabetes. Diabetes technology & therapeutics 26 (S1) (2024)
Jennifer M Yamamoto, Helen R Murphy
Technology and Pregnancy. Diabetes technology & therapeutics 26 (S1) (2024)
David M Maahs, Priya Prahalad, Darja Smigoc Schweiger, Shlomit Shalitin
Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes technology & therapeutics 26 (S1) (2024)
Sarah Sy, Alan Sinclair, Medha Munshi, Anna R Kahkoska, Ruth Weinstock, Tali Cukierman-Yaffe
Use of Technologies at the Advanced Age. Diabetes technology & therapeutics 26 (S1) (2024)
Rayhan Lal, Lalantha Leelarathna
Insulin Delivery Hardware: Pumps and Pens. Diabetes technology & therapeutics 26 (S1) (2024)
Jennifer M Yamamoto, Helen R Murphy
Technology and Pregnancy. Diabetes technology & therapeutics 26 (S1) (2024)
Revital Nimri, Moshe Phillip, Mark A Clements, Boris Kovatchev
Closed-Loop Control, Artificial Intelligence-Based Decision-Support Systems, and Data Science. Diabetes technology & therapeutics 26 (S1) (2024)
Alon Liberman, Katharine Barnard-Kelly
Diabetes Technologies and the Human Factor. Diabetes technology & therapeutics 26 (S1) (2024)
Klemen Dovc, Bruce W Bode, Tadej Battelino
Continuous and Intermittent Glucose Monitoring in 2023. Diabetes technology & therapeutics 26 (S1) (2024)
David M Maahs, Priya Prahalad, Darja Smigoc Schweiger, Shlomit Shalitin
Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes technology & therapeutics 26 (S1) (2024)
Alon Liberman, Katharine Barnard-Kelly
Diabetes Technologies and the Human Factor. Diabetes technology & therapeutics 26 (S1) (2024)

volume 26, number S3, 2024

Pratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, Javier Castañeda, Vittorino Smaniotto, Ohad Cohen
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence. Diabetes technology & therapeutics 26 (S3) (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Elizabeth G Considine, Jennifer L Sherr
Real-World Evidence of Automated Insulin Delivery System Use. Diabetes technology & therapeutics 26 (S3) (2024)
Elizabeth G Considine, Jennifer L Sherr
Real-World Evidence of Automated Insulin Delivery System Use. Diabetes technology & therapeutics 26 (S3) (2024)
Goran Petrovski, Judith Campbell, Maheen Pasha, Khalid Hussain, Amel Khalifa, Fareeda Umer, Douha Almajaly, Manar Hamdar, Tim van den Heuvel, Shannon N Edd
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System. Diabetes technology & therapeutics 26 (S3) (2024)
Goran Petrovski, Judith Campbell, Maheen Pasha, Khalid Hussain, Amel Khalifa, Fareeda Umer, Douha Almajaly, Manar Hamdar, Tim van den Heuvel, Shannon N Edd
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System. Diabetes technology & therapeutics 26 (S3) (2024)
David Norman O'Neal, Dessi P Zaharieva, Dale Morrison, Olivia McCarthy, Kirsten Nørgaard
Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery System. Diabetes technology & therapeutics 26 (S3) (2024)
Goran Petrovski, Judith Campbell, Maheen Pasha, Khalid Hussain, Amel Khalifa, Fareeda Umer, Douha Almajaly, Manar Hamdar, Tim van den Heuvel, Shannon N Edd
Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System. Diabetes technology & therapeutics 26 (S3) (2024)
Bruce A Buckingham, Richard M Bergenstal
Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study. Diabetes technology & therapeutics 26 (S3) (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Benyamin Grosman, Anirban Roy, Louis Lintereur, Kamuran Turksoy, Andrea Benedetti, Toni L Cordero, Robert A Vigersky, Jennifer McVean, Andrew S Rhinehart, Ohad Cohen
A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology. Diabetes technology & therapeutics 26 (S3) (2024)
Halis Kaan Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Satish K Garg, Jennifer J McVean
Development and Future of Automated Insulin Delivery (AID) Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Elizabeth G Considine, Jennifer L Sherr
Real-World Evidence of Automated Insulin Delivery System Use. Diabetes technology & therapeutics 26 (S3) (2024)
Elizabeth G Considine, Jennifer L Sherr
Real-World Evidence of Automated Insulin Delivery System Use. Diabetes technology & therapeutics 26 (S3) (2024)
Gregory P Forlenza, Zheng Dai, Fang Niu, John J Shin
Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Bruce A Buckingham, Richard M Bergenstal
Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study. Diabetes technology & therapeutics 26 (S3) (2024)
Elizabeth G Considine, Jennifer L Sherr
Real-World Evidence of Automated Insulin Delivery System Use. Diabetes technology & therapeutics 26 (S3) (2024)
Chantal Mathieu, Waqas Ahmed, Pieter Gillard, Ohad Cohen, Robert A Vigersky, Simona de Portu, Asli Zeynep Ozdemir Saltik
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review. Diabetes technology & therapeutics 26 (S3) (2024)
James R Thrasher, Arcelia Arrieta, Fang Niu, Katherine R Cameron, Toni L Cordero, John Shin, Andrew S Rhinehart, Robert A Vigersky
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States. Diabetes technology & therapeutics 26 (S3) (2024)
Kathryn Lingen, David Maahs, Natalie Bellini, Diana Isaacs
Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Pratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, Javier Castañeda, Vittorino Smaniotto, Ohad Cohen
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence. Diabetes technology & therapeutics 26 (S3) (2024)
Pratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, Javier Castañeda, Vittorino Smaniotto, Ohad Cohen
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence. Diabetes technology & therapeutics 26 (S3) (2024)
Robert A Vigersky, John Shin
The Myth of MARD ( M ean A bsolute R elative D ifference): Limitations of MARD in the Clinical Assessment of Continuous Glucose Monitoring Data. Diabetes technology & therapeutics 26 (S3) (2024)